Market open · Delayed intraday data · 1:01 PM ET
Last update: Nov 18, 2026, 12:32 PM ET
Elevance Health Inc.
$433.93▼ 2.77% at Nov 17 close
Market Open

Why Elevance Health Inc. (ELV) stock moved

Today so far (12:30 PM ET): ELV is down 5.8% at $408.59 intraday — Driven by sector-wide managed-care and Medicaid margin concerns alongside medical cost trend anxiety (elevated ACA and Medicaid claim utilization), per web research. Delayed intraday figure; the session is confirmed after the close.
Latest session▼ 2.8% · Nov 17, 2026 close

Why Elevance Health Inc. (ELV) fell 2.8% on November 17, 2026

Elevance Health Inc. (ELV) fell 2.8% on November 17, 2026, closing at $433.93 versus $446.28 the prior session (close-to-close, from daily closes). Elevance Health survey reveals 82% of Americans want simplified, personalized healthcare with AI playing a role. Source: Business Wire.

Updated
Prior close
$446.28
Nov 17, 2026 close
$433.93
Change (close-to-close)
−$12.35
−2.77%
As first detected · Nov 17, 2026, 10:17 AM ET

Elevance Health survey reveals 82% of Americans want simplified, personalized healthcare with AI playing a role.

What to watch next: Data supports market demand for AI-driven solutions, potentially validating ELV's digital health strategy and growth opportunities.

Source: Business Wire · percentages in this note are as captured at detection; the confirmed close-to-close move is shown above.

Earlier sessions that moved ELV

  1. +3.9%Driven by positive investor sentiment following management's 2027 growth guidance of at least 12% adjusted EPS growth (highlighted at recent investor conferences including UBS) and strengthening expectations for Medicaid margin recovery in 2027 as state regulators adjust reimbursement rates upward.
  2. +4.9%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
  3. +2.6%Elevance Health filed an earnings report and material event (8-K) today, driving a +2.73% intraday gain to $446.00.
  4. +2.9%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
  5. +4.9%Elevance Health rose 4.9% on September 10, 2026, driven by management's reaffirmation of full-year 2026 earnings per share and cost guidance, which reassured investors about operational stability amid managed-care sector pressures. Read the September 10, 2026 analysis →
  6. +2.7%Following Q2 earnings that beat revenue estimates at $49.83 billion and prompted raised full-year guidance, per Yahoo Finance and WSJ sources.

Elevance Health Inc. (ELV) shares fell 2.8% to $433.93 at the November 17, 2026 close, a moderate decline from the prior close of $446.28. That close is the latest confirmed price for ELV; a live quote was not available. BestStocks flagged the session as a major change for ELV. Below, we break down what changed for ELV, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

ELV fell 2.8% to $433.93

Elevance Health fell 5.26% to $411.09, driven by sector-wide managed-care and Medicaid margin concerns alongside medical cost trend anxiety (elevated ACA and Medicaid claim utilization), per web research. Volume of 551,891 shares in the first 120 minutes represents 1.29x the historical average for this time of day, indicating normal participation for the intraday period. ELV earnings scheduled for January 27, 2027 (consensus EPS estimate $2.08); also monitor Medicaid utilization trends and updates on cost management initiatives that could signal progress toward the projected 2027 margin recovery.

This summary describes the catalyst and move as first detected on Nov 18, 2026, 11:32 AM EST; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
ValuationWeak confidence
Rel. volume
—
Calculating
Vs peers
—
No comparable peers
Market cap
—
Earnings in
70d
2027-01-27
Price chart
Nov 18
Not enough price data.
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Elevance Health Inc. investors

For Elevance Health Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Positive price momentum; ELV rallied +3.09% to $423.15, eclipsing its 52-week high of $422.65 as the stock extended gains driven by sector strength and positive earnings guidance. Weighing against that: Negative session, down 2.8%; Elevance Health reported Q2 2026 earnings before market open showing a sharp 30% year-over-year earnings decline to ~$6.18 per share, driven by surging medical costs and worsening medical loss ratios (Established source, uk.investing.com). BestStocks rates the overall signal quality weak (39/100). With earnings roughly 70 days out, the next report is the most likely near-term test of the move.

ELV price reaction

ELV last traded at $433.93, down $12.35 (-2.77%) from the previous close of $446.28.

The bull and bear case for ELV stock

Weighing the constructive signals against the risks, here is how the bull and bear case for Elevance Health Inc. (ELV) lines up on the latest data.

The bullish case

  • Positive price momentum.
  • ELV rallied +3.09% to $423.15, eclipsing its 52-week high of $422.65 as the stock extended gains driven by sector strength and positive earnings guidance.

The bearish case

  • Negative session, down 2.8%.
  • Elevance Health reported Q2 2026 earnings before market open showing a sharp 30% year-over-year earnings decline to ~$6.18 per share, driven by surging medical costs and worsening medical loss ratios (Established source, uk.investing.com).
Bull vs bear balanceBearish Shift
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst expectations
No analyst data available
SEC filings watch
8-K2026-11-10
Material event — review for impact
high
10-Q2026-10-21
Quarterly financial results
medium
8-K2026-10-21
Material event — review for impact
high
8-K2026-09-10
Material event — review for impact
high
Peer context
ELV-2.8%

Previous notable changes for ELV

News2026-11-17
Elevance Health survey reveals 82% of Americans want simplified, personalized healthcare with AI playing a role.
Valuation2026-11-16via defenseworld.net ↗
Elevance Health rose 3.70% to $445.58, driven by positive investor sentiment following management's 2027 growth guidance of at least 12% adjusted EPS growth (highlighted at recent investor conferences including UBS) and strengthening expectations for Medicaid margin recovery in 2027 as state regulators adjust reimbursement rates upward. The move builds on strong Q3 results reported in late October, where non-GAAP EPS of $6.99 beat expectations and full-year 2026 adjusted EPS guidance was raised to at least $29.00 (per zacks.com and finance.yahoo.com). Volume of 337,661 shares at 90 minutes into the session is running at 1.08x the historical average — normal for this time of day.
News2026-11-12
AM Best assigned bbb+ ratings to Elevance Health's newly filed shelf registration for senior unsecured debt.
Filings2026-11-10
Elevance Health Inc. (ELV) filed a new 8-K on November 10, 2026. The filing contents were not disclosed in available sources.
Upcoming catalysts & outlook
Next earnings
2027-01-27
in 70 days
Thesis shift
Bearish Shift
bearish signal
Risk level
Medium
from change events

Frequently asked questions about ELV

Why did Elevance Health Inc. (ELV) stock move?

Elevance Health Inc. (ELV) fell 2.8% on November 17, 2026, closing at $433.93 versus $446.28 the prior session (close-to-close, from daily closes). Elevance Health survey reveals 82% of Americans want simplified, personalized healthcare with AI playing a role. Source: Business Wire.

How much did ELV stock fall?

ELV lost 2.77% ($12.35) versus the prior close of $446.28, last trading at $433.93.

When is Elevance Health Inc.'s next earnings date?

ELV's next earnings report is scheduled for 2027-01-27 — about 70 days away.

How BestStocks tracks ELV

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared ELV-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for ELV, cross-checked against the data sources listed below. A live intraday quote was not available, so price and volume figures are the confirmed end-of-day close from November 17, 2026 — not the current price — and the percentage move is that session's. They refresh once live quotes resume. For companies with multiple share classes, market-cap figures can differ by data source. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesEarnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.